A 32-week preterm infant with RDS is managed with mechanical ventilation and exogenous surfactant. The clinical team is counseling the parents on complications and long-term outcomes. All of the following are recognized complications or sequelae of RDS and its treatment EXCEPT:

Explanation

## Complications of RDS and Its Management ### Bronchopulmonary Dysplasia (BPD) **Key Point:** BPD is a chronic lung disease of prematurity resulting from: - Prolonged mechanical ventilation (barotrauma, volutrauma) - High oxygen exposure (hyperoxia) - Infection and inflammation - Inadequate antioxidant defenses in immature lungs **Clinical Pearl:** Modern "gentle ventilation" strategies (permissive hypercapnia, synchronized ventilation, early CPAP) have reduced BPD incidence, but it remains a major morbidity in extremely preterm infants. ### Pulmonary Hypoplasia **High-Yield:** Pulmonary hypoplasia is **NOT a direct consequence of RDS itself**. Rather, it is a **pre-existing structural abnormality** caused by: - Congenital diaphragmatic hernia - Severe oligohydramnios (Potter sequence) - Bilateral renal agenesis - Skeletal dysplasias **Warning:** Do not confuse pulmonary hypoplasia (underdevelopment of lung tissue) with RDS (surfactant deficiency). However, a preterm infant with RDS may have **coexisting** pulmonary hypoplasia if there was intrauterine growth restriction or other developmental insult. ### Retinopathy of Prematurity (ROP) **Key Point:** ROP is a vasoproliferative disorder of the retina caused by **abnormal vascularization** in response to: - Hyperoxia (high SpO~2~, high PaO~2~) - Hypoxia (rebound vasoconstriction) - Fluctuating oxygen levels **Mnemonic: STOP-ROP** — **S**upplemental **T**herapeutic **O**xygen **P**revention of **ROP** **Critical High-Yield:** Current evidence-based SpO~2~ targets for preterm infants are: - **90–95%** in infants <32 weeks or <1500 g (SUPPORT, COT trials) - Maintaining SpO~2~ at **85–89%** is **TOO LOW** and increases risk of: - Hypoxic episodes - Pulmonary hypertension - Increased mortality - Does NOT reliably prevent ROP **Clinical Pearl:** The goal is to avoid **both** hyperoxia and hypoxia; tight SpO~2~ control (90–95%) with minimal fluctuation is optimal. ### Intraventricular Hemorrhage (IVH) **High-Yield:** IVH is a major complication in preterm infants with RDS due to: 1. **Fluctuating cerebral blood flow** from: - Hypoxemia and hypercapnia (vasodilation) - Mechanical ventilation (increased intrathoracic pressure) - Rapid fluid shifts 2. **Fragile germinal matrix vasculature** (especially <32 weeks) 3. **Impaired autoregulation** of cerebral blood flow **Clinical Pearl:** Antenatal corticosteroids and gentle ventilation strategies reduce IVH risk by stabilizing cerebral hemodynamics. ## Summary Table: RDS Complications | Complication | Mechanism | Risk Factors | Prevention | | --- | --- | --- | --- | | BPD | Barotrauma, hyperoxia, inflammation | Prolonged ventilation, high FiO~2~ | Gentle ventilation, early CPAP, antioxidants | | ROP | Hyperoxia + hypoxia + fluctuation | SpO~2~ >95%, rapid changes | Target SpO~2~ 90–95%, minimize fluctuation | | IVH | Fluctuating cerebral blood flow | Hypoxia, hypercapnia, ventilation | Antenatal steroids, gentle ventilation, avoid rapid changes | | Pulmonary hypoplasia | **Pre-existing structural underdevelopment** | Oligohydramnios, diaphragmatic hernia | Prenatal diagnosis, delivery planning | ## Why Option 2 Is Incorrect **The statement "ROP is prevented by maintaining SpO~2~ in the range of 85–89%" is FALSE.** - SpO~2~ of 85–89% is **too low** for preterm infants and increases risk of: - Hypoxic episodes - Pulmonary hypertension - Increased mortality - Current guidelines recommend **90–95%** SpO~2~ as the target - ROP prevention requires **stable, normoxic SpO~2~** (90–95%) with minimal fluctuation, not deliberately low SpO~2~